Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use.

American journal of obstetrics and gynecology - 1 May 2012

Haas David M, Lehmann Amalia S, Skaar Todd, Philips Santosh, McCormick Catherine L, Beagle Kyle, Hebbring Scott J, Dantzer Jessica, Li Lang, Jung Jeesun

Abstract excerpt

OBJECTIVE: To determine the impact of maternal and fetal single nucleotide polymorphisms in key betamethasone pathways on neonatal outcomes. STUDY DESIGN: DNA was obtained from women given betamethasone and their infants. Samples were genotyped for 73 exploratory drug metabolism and glucocorticoi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenylyl Cyclases
Share to Arylsulfotransferase
Share to CRF Receptor, Type 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucocorticoids

Share to Obstetric Labor, Premature

Share to Receptors, Corticotropin-Releasing Hormone

Share to Receptors, Glucocorticoid

Share to Respiratory Distress Syndrome, Newborn

Source

Open in PubMed Open full text

Identifiers

PMID: 22445700
DOI: 10.1016/j.ajog.2012.02.016
PMCID: PMC3340461

Genes

ADCY9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22445700-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use.PMID 22445700Read ↗

The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration.Semantic proximity Read ↗

Steroid Pathway Genes and Neonatal Respiratory Distress After Betamethasone Use in Anticipated Preterm Birth.Semantic proximity Read ↗

Neonatal Genetic Variation in Steroid Metabolism and Key Respiratory Function Genes and Perinatal Outcomes in Single and Multiple Courses of Corticosteroids.Semantic proximity Read ↗

Systemic Steroid Exposure Is Associated with Differential Methylation in Chronic Obstructive Pulmonary DiseaseSemantic proximity Read ↗

DNA methylation signatures in human neonatal blood following maternal antenatal corticosteroid treatmentSemantic proximity Read ↗

ST13 polymorphisms and their effect on exacerbations in steroid-treated asthmatic children and young adults.Semantic proximity Read ↗

Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes.Semantic proximity Read ↗

Variations in opioid receptor genes in neonatal abstinence syndrome.Semantic proximity Read ↗

Neonatal medications.Semantic proximity Read ↗

Maternal Betamethasone for Prevention of Respiratory Distress Syndrome in Neonates: Population Pharmacokinetic and Pharmacodynamic Approach.Semantic proximity Read ↗

Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.Semantic proximity Read ↗

Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.